Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactate for Major Depressive Disorder
NCT06168175Phase 2Not yet recruiting
- Sponsor
- Lausanne University Hospital
- Start
- Jan 2024
- Primary completion
- Jan 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lactated ringer's solution in major depressive disorder (MDD), sponsored by Lausanne University Hospital. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
lactated ringer's solution
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06168175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06168175.